证券时报e公司讯，艾德生物10月25日晚间公告，公司于近日获得由国家药监局颁发的人类IDH1基因突变检测试剂盒《中华人民共和国医疗器械注册证》。

格隆汇10月25日丨艾德生物(300685.SZ)公布，公司于近日获得由国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》，产品名称为人类IDH1基因 ...

In osteosarcoma, ATRX mutations cause the formation of an ALT. All four tumors are closely related to the formation of ALT. The combination of IDH1 R132H /p53mut and ATRX loss induces immune escape by ...

The FDA approved a companion diagnostic for vorasidenib for patients with grade 2 astrocytoma or oligodendroglioma. The FDA approved a companion diagnostic called the Ion Torrent Oncomine Dx Target ...